Drug Detail:Castor oil (monograph) (Medically reviewed)
Drug Class:
Usual Adult Dose for Constipation - Acute
15 to 60 mL orally once a day (as a single dose) OR as otherwise directed
Comments:
- This drug may be taken with juice.
- Treatment should be limited to up to 1 week of use (unless otherwise necessary) to risk of laxative dependence.
Use: Temporary relief of occasional constipation
Usual Adult Dose for Constipation
15 to 60 mL orally once a day (as a single dose) OR as otherwise directed
Comments:
- This drug may be taken with juice.
- Treatment should be limited to up to 1 week of use (unless otherwise necessary) to risk of laxative dependence.
Use: Temporary relief of occasional constipation
Usual Pediatric Dose for Constipation - Acute
2 to under 12 years: 5 to 15 mL orally once a day (as a single dose) OR as otherwise directed
12 years and older: 15 to 60 mL orally once a day (as a single dose) OR as otherwise directed
Comments:
- This drug may be taken with juice.
- Treatment should be limited to up to 1 week of use (unless otherwise necessary) to risk of laxative dependence.
Use: Temporary relief of occasional constipation
Usual Pediatric Dose for Constipation
2 to under 12 years: 5 to 15 mL orally once a day (as a single dose) OR as otherwise directed
12 years and older: 15 to 60 mL orally once a day (as a single dose) OR as otherwise directed
Comments:
- This drug may be taken with juice.
- Treatment should be limited to up to 1 week of use (unless otherwise necessary) to risk of laxative dependence.
Use: Temporary relief of occasional constipation
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
- In patients with abdominal pain, nausea, or vomiting UNLESS otherwise directed
Safety and efficacy have not been established in patients younger than 2 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- This drug should be taken on an empty stomach.
Storage requirements:
- This drug should be kept tightly closed and out of excessive heat.
Monitoring:
- GASTROINTESTINAL: Sudden, persistent bowel function changes over 2 weeks; rectal bleeding or continued constipation during treatment
Patient advice:
- Advise patients to speak to their healthcare provider if they become pregnant, intend to become pregnant, or are breastfeeding.
